Publications by authors named "Fabrizio Comper"

Claim this Profile
F
FLT201, a novel liver-directed AAV gene therapy candidate for Gaucher disease type 1.
Fabrizio Comper, Carlos J Miranda, Benjamin Liou, Tihomir Dodev, Jey M Jeyakumar

Mol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.
Chiara Romani, Fabrizio Comper, Elisabetta Bandiera, Antonella Ravaggi, Eliana Bignotti

Am J Obstet Gynecol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Fabrizio Comper, Davide Antonello, Stefania Beghelli, Stefano Gobbo, Licia Montagna

Am J Surg Pathol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Alessandro D Santin, Stefania Bellone, Moira Marizzoni, Michela Palmieri, Eric R Siegel, Fabrizio Comper

Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminal deletion affects catalytic activity of saporin toxin.
Francesca Bonini, Roberta Traini, Fabrizio Comper, Giulio Fracasso, Rossella Tomazzolli

J Cell Biochem· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis